Association between RCII/eGDR ratio and cardiovascular disease in Chinese middle-aged and older adults: evidence from the CHARLS cohort

Abstract Aims Cardiovascular diseases (CVD) are the leading global causes of death and disability. The residual cholesterol inflammation index (RCII) and estimated glucose disposal rate (eGDR) reflect inflammatory-metabolic risk and insulin resistance, respectively. However, their combined predictive capacity remains unclear. This study examined the associations between the RCII/eGDR ratio and risks of CVD, stroke, and heart disease. Materials and methods This study included 6,981 baseline CVD-free adults aged ≥ 45 years from the CHARLS cohort. Cox proportional hazards regression, with progressive adjustment for confounders, and restricted cubic spline (RCS) models were used to assess associations between the RCII/eGDR ratio and risks of CVD, stroke, and heart disease. Results After a median 9-year follow-up, incident CVD, stroke, and heart disease occurred in 23.7%, 8.3%, and 18% of participants, respectively. In fully adjusted models, each 1-unit increase in RCII/eGDR was associated with a 4% higher CVD risk (HR = 1.04, 95% CI: 1.01–1.06) and a 7% higher stroke risk (HR = 1.07, 95% CI: 1.04–1.10), but was not significantly associated with heart disease (HR = 1.02, 95% CI: 0.99–1.06; P = 0.163). Quartile-based analyses showed graded higher risks across ascending RCII/eGDR quartiles. Relative to Q1, Q3 and Q4 exhibited significantly elevated CVD (Q3: HR = 1.40, 95% CI: 1.21–1.61; Q4: HR = 1.56, 95% CI: 1.35–1.79), stroke (Q3: HR = 1.74, 95% CI: 1.35–2.23; Q4: HR = 2.02, 95% CI: 1.58–2.59), and heart disease risks (Q3: HR = 1.34, 95% CI: 1.14–1.58; Q4: HR = 1.46, 95% CI: 1.24–1.71). RCS models confirmed nonlinear dose-response relationships for all three outcomes. Conclusions Elevated RCII/eGDR was associated with higher risks of CVD, stroke, and heart disease. As a convenient composite marker integrating metabolic and inflammatory status, it may offer potential value for cardiovascular risk stratification in Chinese middle-aged and older adults.

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2026-09-17
DOI
https://doi.org/10.1186/s12872-026-06628-5
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Association between RCII/eGDR ratio and cardiovascular disease in Chinese middle-aged and older adults: evidence from the CHARLS cohort

Jiaqi Ren, Xin Fu, Jian Kang, Guannan Ai et al.
BMC Cardiovascular Disorders
Inflammatory Biomarkers in Disease Prognosis
article

Association between RCII/eGDR ratio and cardiovascular disease in Chinese middle-aged and older adults: evidence from the CHARLS cohort

Jiaqi Ren, Xin Fu, Jian Kang, Guannan Ai, Meijia Cheng, Xize Wu, Lihong Gong, Yue Li, Bo Wang, Xiaoning Sun
article en

Abstract

Abstract Aims Cardiovascular diseases (CVD) are the leading global causes of death and disability. The residual cholesterol inflammation index (RCII) and estimated glucose disposal rate (eGDR) reflect inflammatory-metabolic risk and insulin resistance, respectively. However, their combined predictive capacity remains unclear. This study examined the associations between the RCII/eGDR ratio and risks of CVD, stroke, and heart disease. Materials and methods This study included 6,981 baseline CVD-free adults aged ≥ 45 years from the CHARLS cohort. Cox proportional hazards regression, with progressive adjustment for confounders, and restricted cubic spline (RCS) models were used to assess associations between the RCII/eGDR ratio and risks of CVD, stroke, and heart disease. Results After a median 9-year follow-up, incident CVD, stroke, and heart disease occurred in 23.7%, 8.3%, and 18% of participants, respectively. In fully adjusted models, each 1-unit increase in RCII/eGDR was associated with a 4% higher CVD risk (HR = 1.04, 95% CI: 1.01–1.06) and a 7% higher stroke risk (HR = 1.07, 95% CI: 1.04–1.10), but was not significantly associated with heart disease (HR = 1.02, 95% CI: 0.99–1.06; P = 0.163). Quartile-based analyses showed graded higher risks across ascending RCII/eGDR quartiles. Relative to Q1, Q3 and Q4 exhibited significantly elevated CVD (Q3: HR = 1.40, 95% CI: 1.21–1.61; Q4: HR = 1.56, 95% CI: 1.35–1.79), stroke (Q3: HR = 1.74, 95% CI: 1.35–2.23; Q4: HR = 2.02, 95% CI: 1.58–2.59), and heart disease risks (Q3: HR = 1.34, 95% CI: 1.14–1.58; Q4: HR = 1.46, 95% CI: 1.24–1.71). RCS models confirmed nonlinear dose-response relationships for all three outcomes. Conclusions Elevated RCII/eGDR was associated with higher risks of CVD, stroke, and heart disease. As a convenient composite marker integrating metabolic and inflammatory status, it may offer potential value for cardiovascular risk stratification in Chinese middle-aged and older adults.

BMC Cardiovascular Disorders
Shenyang Medical College (CN), Liaoning University of Traditional Chinese Medicine (CN), Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
Department of Science and Technology of Liaoning Province
Good health and well-being
Openalex Percentile: Top 14%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.